Duncan joined Brandon Capital Partners 2016.
Before joining Duncan was the Chief Executive of WaikatoLink the commercialisation company of the University of Waikato, Hamilton, New Zealand. Duncan has led a range of initiatives including KiwiNet, a consortium of 15 New Zealand research organisations to facilitate commercialisation. Duncan has a particular interest in the agritech, animal health and life science sectors, is founder of a number of start-up ventures and has held directorships with Aduro Biopolymers, Ligar Polymers, Aldera Animal Health, PA Therapeutics and Auramer Bio. Earlier, Duncan spent 5 years in clinical veterinary practice including leadership roles during the 2001 foot and mouth outbreak in the UK.
Duncan is currently Executive Chairman of Kea Therapeutics.
Duncan has a Bachelor of Veterinary Science from Massey University.